McClung et al., 2003 - Google Patents
Effect of creatine supplementation on cardiac muscle of exercise-stressed ratsMcClung et al., 2003
- Document ID
- 2630168216092603624
- Author
- McClung J
- Hand G
- Davis J
- Carson J
- Publication year
- Publication venue
- European journal of applied physiology
External Links
Snippet
The role of creatine supplementation in altering the physiological parameters regulating cardiac muscle's functional capacity through the initiation of cardiac hypertrophy and altered contractile protein expression has not been determined. The purpose of this study was to …
- 230000001502 supplementation 0 title abstract description 52
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cheserek et al. | Cardioprotective effects of lipoic acid, quercetin and resveratrol on oxidative stress related to thyroid hormone alterations in long-term obesity | |
| US20220249453A1 (en) | Compositions and methods using trigonelline to produce intracellular nicotinamide adenine dinucleotide (nad+) for treating or preventing physiological disorders or states | |
| Rooney et al. | Creatine supplementation alters insulin secretion and glucose homeostasis in vivo | |
| Benoit et al. | Pasture v. standard dairy cream in high-fat diet-fed mice: improved metabolic outcomes and stronger intestinal barrier | |
| Lavorato et al. | Effects of aerobic exercise training and açai supplementation on cardiac structure and function in rats submitted to a high-fat diet | |
| Cruzat et al. | Current aspects about oxidative stress, physical exercise and supplementation | |
| Borbon et al. | Lack of efficacy of curcumin on neurodegeneration in the mouse model of Niemann–Pick C1 | |
| EP3993789A1 (en) | Compositions and methods using trigonelline and high protein for preventing or treating conditions or disorders in skeletal muscle | |
| McClung et al. | Effect of creatine supplementation on cardiac muscle of exercise-stressed rats | |
| Jia et al. | Evaluation of silymarin extract from Silybum marianum in mice: anti-fatigue activity | |
| Kirana et al. | Aqueous extract of Garcinia indica choisy restores glutathione in type 2 diabetic rats | |
| Ross-Inta et al. | Threonine-deficient diets induced changes in hepatic bioenergetics | |
| Kim et al. | Prunus mume extract ameliorates exercise-induced fatigue in trained rats | |
| Nandave et al. | Cardioprotective response to chronic administration of vitamin E in isoproterenol induced myocardial necrosis: hemodynamic, biochemical and ultrastructural studies | |
| AU2020310497A1 (en) | Compositions and methods using trigonelline to produce intracellular NAD+ | |
| Azuma et al. | Long-term effect of taurine in congestive heart failure: preliminary report | |
| Prokopov | Intermittent Hypoxia and Health: From Evolutionary Aspects to Mitochondria Rejuvenation | |
| AU2007352854A1 (en) | Branched-chain amino acid composition for improving skeletal muscle protein metabolism | |
| Arutyunyan et al. | The use of different experimental models of hyperhomocysteinemia in neurochemical studies | |
| Salama et al. | A comparison between the impact of two different exercise protocols on advanced glycation end products in type 2 diabetic rats | |
| US7993685B2 (en) | Branched-chain amino acid composition for improving skeletal muscle protein metabolism | |
| Bautista et al. | Late-in-life Exercise Ameliorates the Aging Trajectory Metabolism Programmed by Maternal Obesity in Rats: It is Never Too Late | |
| EP3989999B1 (en) | New composition containing branched-chain amino acids | |
| US20070117867A1 (en) | Kit comprising three independent compositions and methods for building muscle, increasing strength, increasing muscle size, increasing muscle performance and reducing muscle fatigue | |
| CA2598786C (en) | Composition and method for increasing the anabolic state of muscle cells |